Estudios originales
Published on 23 de enero de 2025 | http://doi.org/10.5867/medwave.2025.01.2946
Surgical outcomes, survival and prognostic factors in a cohort of lung cancer patients operated at the University of Chile Clinical Hospital
Back to article
Distribution of clinical and pathological stage after surgery.
| I | 50 | 47 |
| IA1 | 1 | 0.9 |
| IA2 | 16 | 14.9 |
| IA3 | 17 | 15.8 |
| IB | 16 | 14.9 |
| II | 29 | 27 |
| IIA | 8 | 7.5 |
| IIB | 21 | 19.6 |
| III | 28 | 26 |
| IIIA | 23 | 25.2 |
| IIIB | 4 | 3.7 |
| IIIC | 1 | 0.9 |
| IV | 0 | 0 |
| IVA | 0 | 0 |
| IVB | 0 | 0 |
| 0 | 3 | 2.8 |
| I | 37 | 41.8 |
| IA1 | 2 | 1.9 |
| IA2 | 16 | 14.9 |
| IA3 | 8 | 7.5 |
| IB | 11 | 10.3 |
| II | 35 | 32.7 |
| IIA | 9 | 8.4 |
| IIB | 26 | 24.3 |
| III | 31 | 28.9 |
| IIIA | 26 | 24.3 |
| IIIB | 4 | 3.7 |
| IIIC | 1 | 0.9 |
| IV | 1 | 0.9 |
| IVA | 1 | 0.9 |
| IVB | 0 | 0 |
Data from the cohort of lung cancer patients operated on with curative intent at the Hospital Clínico de la Universidad de Chile, period from 2004 to 2015.
Source: Prepared by the authors based on the study results.